Fed. Circ. Makes It Binding: Arthrex Redo Is For Patent Owner

The Federal Circuit on Tuesday reissued as precedent its ruling that patent challengers can't leverage Arthrex to get a new hearing at the Patent Trial and Appeal Board, following the U.S....

Already a subscriber? Click here to view full article